Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer

1 Dec 2017

Abstract excerpt

Colorectal cancer (CRC) screening is the most efficient strategy to reduce disease-related mortality. Frequent aberrant DNA methylation is known to occur in selected genes and early during CRC development, which has emerged as a new epigenetic biomarker for early detection of CRC. Previously, we reported that we identified that CpG sites of SDC2 were aberrantly methylated in tumor tissues of most CRC patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Gastric Cancer Management and Outcomes
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29225717
DOI: 10.1186/s13148-017-0426-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancerPMID 29225717Read ↗

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNASemantic proximity Read ↗

A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNASemantic proximity Read ↗

A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized TrialSemantic proximity Read ↗

Methylation of SDC2/TFPI2 and Its Diagnostic Value in Colorectal Tumorous LesionsSemantic proximity Read ↗

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early DetectionSemantic proximity Read ↗

Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal NeoplasiaSemantic proximity Read ↗

Evaluating the Clinical Performance of SDC2/NDRG4 Methylation for Colorectal Cancer DetectionSemantic proximity Read ↗

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal CancerSemantic proximity Read ↗

Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.Semantic proximity Read ↗

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancerSemantic proximity Read ↗

DNA methylation analysis of SCD2, SEPT9 and VIM genes for the early detection of colorectal cancer in fecal DNASemantic proximity Read ↗

DNA methylation analysis of the SDC2, SEPT9 and VIM genes in fecal DNA for colorectal cancer diagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.